FRED X – Will surface treatment be a game changer in flow diversion?

From LINNC Paris 2022, Professors Laurent Pierot and Markus A. Möhlenbruch take a deeper look at the innovative FRED X technology and discuss how surface treatment could positively impact on neurovascular strategies in the future.
 
Outlining preliminary data from the FRED X multicentric series, Prof. Möhlenbruch discusses the FRED X technology, a proprietary nanoscale surface treatment developed by Terumo and designed to reduce material thrombogenicity while maintaining natural healing response.

 

INTERVIEW

Safe and exemplary occlusion for wide neck bifurcation aneurysms using the Microvention WEB system

INTERVIEW

The CLEVER Study – WEB 17 for Ruptured and Unruptured Aneurysms

INTERVIEW

Microvention Symposium - CLEVER Study & FRED X Multicenter registry

INTERVIEW

X-Technology Surface Treatment: Mechanism of Action

INTERVIEW

What happens when you take one of the best flow diverters in use today and engineer surface modification?